com) and distributed 300,000 copies of a documentary called "George W. Bush: Faith in the white House" directly to churches (Smith, 2006, p
Christine Todd Whitman, who served Bush as administrator of the Environmental Protection Agency in Bush's first term (she served from January 2001 to May 2003), and was the first female governor of New Jersey, supported embryonic stem cell research. Whitman noted in her book that right after Bush was re-elected in 2004, Christian conservative organizer Phil Burress was heard to say, "The president rode our coattails" (Whitman, 2006)
There is little question that the main source of stem cells is and is very likely to continue to be primarily from human embryonic tissue. Because of this, the vast majority of tissue used in stem cell research either comes from the tissue of aborted pregnancies, or from the "left over" or surplus embryos from fertility clinics (Berger, 2001)
. Scientists left to themselves may not always make the best ethics decisions (Nizza, 2004)
.is the destruction of the very early embryo immoral? Second, if a vaccine or tissue is generated from these human embryonic stem cells, would someone act unethically in using it (Shannon, 2004)?" For many, like the Catholics, the resounding answer to this question is that it is not moral to "use" human embryos, and that they are to be "
The only difference is that pro-life supporters are not taking a similar kind of stance on the issue in comparison with stem cell treatment. (Chad, 2004, pp
As a result, the majority of embryos and sperm are destroyed most of the time with this procedure. (Pence, 2007, pp
Whereas many proponents of stem cell research will argue that the entire process is designed to prevent these kinds of incidents. (Plunkett, 2007) to show how proponents of stem cell research are correct requires comparing the viewpoints of both sides
" This is significant, in showing how parthenogenesis is effective in being able produce stem cells. (Qingyun, 2007, pg
This is when the writer will create content that will agree with audience and challenge their thinking. (Snyder, 2009, pp
This means that these kinds of cells have the same types of properties as embryos and can be utilized for similar kinds of purposes. (Yidrim, 2011, pp
Stem cell treatment is one area of great promise, and has been studied as a potential treatment in many neurological conditions, such as Alzheimer's, Parkinson's Disease, Stroke patients, Cerebral Palsy, Autism, and the more rare genetic disorders, such as Angelman Syndrome (Rossi & Cattaneo, 401-409). It is with much critical thought to offer this point of question: there exists more than some slight potential of these disorders sharing common biological markers within the brain, and therefore offer the thought that what might be a viable therapeutic in one area, may indeed hold potential in neurological conditions overall (Abuhatzira, Shemer, & Razin, 2009)
Significant progress has been made which tackles ethical and political issues, such as using induced pluripotent cells derived from somatic cells rather than embryonic cells. Induced pluripotent cells are cells that have been altered in the lab to become pluripotent, meaning they have the potential to develop into almost any type of body cell (Condic & Rao, 2008)
children with AS reveals a clinical worsening of the phenotype. This may be due to the brain developing around a dendritic defect, as well as the destructive power of intractable epilepsy (Dindot, Antalffy, Meenakshi, & Beaudet, 2008)
The mechanism involved in producing these cells is through genetically coaxing an ordinary body cell, called a somatic cell, into becoming a stem cell. Somatic cells lack the ethical problems that embryonic cells have, though hypothetically they should have the same potential to treat diseases, ailments and injuries in many fields of medicine (Dobkin, 2007)
¶ … Induced Pluripotent Stem Cells to Treat the Severe Neurological Disorder Angelman Syndrome With Additional Theoretical Application to Treating Other Neurological Disorders Concepts, Issues, and Definitions Statement of General Topic Area: Neurological Disorders and Stem Cell Treatment Angelman Syndrome Induced Pluripotent Stem Cell Research Possibilities for therapeutic cross-over benefit to other Neurological Disorders Animal Model for Testing Potential Therapeutic and Other Areas of Concern Concepts, Issues, and Definitions Statement of Purpose The possibility of stem cell treatment as a therapeutic and/or as a cure for many disorders has been widely studied. Barriers to success have been political, social, ethical, and scientific (Fischback & Fischback, 2004)
Most individuals with AS have a seizure disorder. Intractable epilepsy is a primary area of concern in managing the outcome of Angelman Syndrome (Galanopoulou, 2010)
This animal model does not have the maternally active copy of the UBE3A gene. Additionally, the early generation UBE3A-null models led to a demand for a model that held all the functions of the null-model, while including the ability to "report" on the status of UBE3A via a fluorescent signature marker in the brain, where UBE3A was active (Heck, Zhao, Snigdha, & LeDoux, 2008)
This newer generation of the UBE3A-null model is called the UBE3A Reporter Mouse. The advantage is that, in vivo, the research scientist is able to stain the slices and view any neural genetic activity of an attempted rescue of the phenotype, in order to ascertain any success and/or to what degree success occurred (Landers, Calciano, Colosi, Wagstaff, Glatt-Deeley, & Lalande, 2005)
1.3 State of General Topic Area: Neurological Disorders and Stem Cell Treatment Neurological disorders have been a hardship for society and individuals, with costs extending beyond healthcare costs (MacDonald, Cockerell, & Sander, 2000)